Reneuron Share Price (RENE)

I don't really understand why Olav would say they're still looking to partner CTX for stroke in other territories, and then going on to say they probably don't need to put CTX into the brain, exosomes would do it.

Really useful, thanks for sharing. Much more info than the prelims presentation.

I don't think this has been shared yet? November's analyst briefing, rather than the Investor Meet presentation of the same day.

Good, in-depth discussion. An interesting comment about CTX for stroke, especially considering yesterday's slightly cryptic update.

https://webcasting.brrmedia.co.uk/broadcast/619e306356c12f2f14319b16

There was a time when Fosun was to be the saviour of our world, delivering an abundance of riches, but we’re about to cash a cheque for half a million bucks, from which we’ll need to deduct I presume international lawyers’ fees. Now of course we’ve moved our attention and hopes onto exosomes and it’s pre-clinical trials, but even with a fair wind it’s probably several years of development out. If one subscribes to the concept of an efficient market, as I do, and think it’s both appealing intellectually and remarkably well supported by the facts, then perhaps a buck a share is presently a realistic price.
Nonetheless I continue to enjoy reading our optimism and equally recording an alternative spin, but like everyone else I hope this will soon be a $50 share, albeit I’m not seeing much evidence to support that aspiration nor does the market. But I’ll hang on just in case and hope others’ dreams come true sooner than I expect! Have a good weekend and fingers crossed that the Board has better access to information than we or the market does.

Sorry meant to say indeed, it does just seem to be an update to say they can submit an invoice. Strange to call it an additional agreement if that's all it is, strange not to tell us what the additional agreement is, if there's more to it.